|
[1]
|
Shah, S.V. and Fonseca, V.A. (2011) Iron and Diabetes Revisited. Diabetes Care, 34, 1676-1677.
http://dx.doi.org/10.2337/dc11-0700
|
|
|
[2]
|
Bowers, K., Yeung, E., Williams, M.A., Qi, L., Tobias, D.K., et al. (2011) A Prospective Study of Prepregnancy Dietary Iron Intake and Risk for Gestational Diabetes Mellitus. Diabetes Care, 34, 1557-1563.
http://dx.doi.org/10.2337/dc11-0134
|
|
|
[3]
|
Swaminathan, S., Fonseca, V.A., Alam, M.G. and Shah, S.V. (2007) The Role of Iron in Diabetes and Its Complications. Diabetes Care, 30, 1926-1933.
http://dx.doi.org/10.2337/dc06-2625
|
|
|
[4]
|
McClain, D.A., Abraham, D., Rogers, J., Brady, R., Gault, P., et al. (2006) High Prevalence of Abnormal Glucose Homeostasis Secondary to Decreased Insulin Secretion in Individuals with Hereditary Haemochromatosis. Diabetologia, 49, 1661-1669.
http://dx.doi.org/10.1007/s00125-006-0200-0
|
|
|
[5]
|
Fernández-Real, J.M., López-Bermejo, A. and Ricart, W. (2002) Cross-Talk between Iron Metabolism and Diabetes. Diabetes, 51, 2348-2354.
http://dx.doi.org/10.2337/diabetes.51.8.2348
|
|
|
[6]
|
Jaruratanasirikul, S., Chareonmuang, R., Wongcharnchailert, M., Laosombat, V., Sangsupavanich, P. and Leetanaporn, K. (2008) Prevalence of Impaired Glucose Metabolism in Beta-Thalassemic Children Receiving Hypertransfusions with a Suboptimal Dosage of Iron-Chelating Therapy. European Journal of Pediatrics, 167, 873-876.
http://dx.doi.org/10.1007/s00431-007-0602-0
|
|
|
[7]
|
Simcox, J.A. and McClain, D.A. (2013) Iron and Diabetes Risk. Cell Metabolism, 17, 329-341.
http://dx.doi.org/10.1016/j.cmet.2013.02.007
|
|
|
[8]
|
Hirabara, S.M., Gorjao, R., Vinolo, M.A., Rodrigues, A.C., Nachbar, R.T. and Curi, R. (2012) Molecular Targets Related to Inflammation and Insulin Resistance and Potential Interventions. Journal of Biomedical Science, 2012, 16 p.
|
|
|
[9]
|
Gabrielsen, J.S., Gao, Y., Simcox, J.A., Huang, J., Thorup, D., et al. (2012) Adipocyte Iron Regulates Adiponectin and Insulin Sensitivity. Journal of Clinical Investigation, 122, 3529-3540.
http://dx.doi.org/10.1172/JCI44421
|
|
|
[10]
|
Blaslov, K., Bulum, T., Zibar, K. and Duvnjak, L. (2013) Relationship between Adiponectin Level, Insulin Sensitivity, and Metabolic Syndrome in Type 1 Diabetic Patients. International Journal of Endocrinology, 2013, 6 p.
|
|
|
[11]
|
Qiu, C., Zhang, C., Gelaye, B., Enquobahrie, D.A., Frederick, I.O. and Williams, M.A. (2011) Gestational Diabetes Mellitus in Relation to Maternal Dietary Heme Iron and Nonheme Iron Intake. Diabetes Care, 34, 1564-1569.
http://dx.doi.org/10.2337/dc11-0135
|
|
|
[12]
|
Fernández-Real, J.M., Penarroja, G., Castro, A., García-Bragado, F., Hernández-Aguado, I. and Ricart, W. (2002) Blood Letting in High-Ferritin Type 2 Diabetes: Effect on Insulin Sensitivity and β-Cell Function. Diabetes, 51, 1000-1004.
http://dx.doi.org/10.2337/diabetes.51.4.1000
|
|
|
[13]
|
Ascherio, A., Rimm, E.B., Giovannucci, E., Willett, W.C. and Stampfer, M.J. (2001) Blood Donations and Risk of Coronary Heart Disease in Men. Circulation, 103, 52-57.
http://dx.doi.org/10.1161/01.CIR.103.1.52
|
|
|
[14]
|
Montosi, G., Garuti, C., Martinelli, S. and Pietrangelo, A. (1998) Hepatic Stellate Cells Are Not Subjected to Oxidative Stress Iron-Induced Fibrogenesis in Rodents. Hepatology, 27, 1611-1622.
http://dx.doi.org/10.1002/hep.510270622
|
|
|
[15]
|
Adams, P., Brissot, P. and Powell, L.W. (2000) EASL International Consensus Conference on Hemochromatosis. Journal of Hepatology, 33, 485-504.
http://dx.doi.org/10.1016/S0168-8278(01)80874-6
|
|
|
[16]
|
Cooksey, R.C., Jones, D., Gabrielsen, S., Huang, J., Simcox, J.A., et al. (2010) Dietary Iron Restriction or Iron Chelation Protects from Diabetes and Loss of Beta-Cell Function in the Obese (ob/ob lep-/-) Mouse. American Journal of Physiology-Endocrinology and Metabolism, 298, E1236-E1243.
http://dx.doi.org/10.1152/ajpendo.00022.2010
|
|
|
[17]
|
Houschyar, K.S., Ludtke, R., Dobos, G.J., Kalus, U., Broecker-Preuss, M., et al. (2012) Effects of Phlebotomy-Induced Reduction of Body Iron Stores on Metabolic Syndrome: Results from a Randomized Clinical Trial. BMC Medicine, 10, 54-62.
http://dx.doi.org/10.1186/1741-7015-10-54
|
|
|
[18]
|
Crowley, M.J., Holleman, R., Klamerus, M.L., Bosworth, H.B., Edelman, D. and Heisler, M. (2014) Factors Associated with Persistent Poorly Controlled Diabetes Mellitus: Clues to Improving Management in Patients with Resistant Poor Control. Chronic Illness, 10, 291-302.
http://dx.doi.org/10.1177/1742395314523653
|
|
|
[19]
|
Adams, P., Brissot, P. and Powell, L.W. (2000) EASL International Consensus Conference on Haemochromatosis. Journal of Hepatology, 33, 485-504.
http://dx.doi.org/10.1016/S0168-8278(01)80874-6
|
|
|
[20]
|
Valenti, L., Fracanzani, A.L., Dongiovani, P., Bugianesi, E., Marchesini, G., et al. (2007) Iron Depletion by Phlebotomy Improves Insulin Resistance in Patients with Nonalcoholic Fatty Liver Disease and Hyperferritinemia: Evidence from a Case-Control Study. The American Journal of Gastroenterology, 102, 1251-1258.
http://dx.doi.org/10.1111/j.1572-0241.2007.01192.x
|
|
|
[21]
|
Dongiovanni, P., Ruscica, M., Rametta, R., Recalcati, S., Steffani, L., et al. (2013) Dietary Iron Overload Induces Visceral Adipose Tissue Insulin Resistance. The American Journal of Pathology, 182, 2254-2263.
http://dx.doi.org/10.1016/j.ajpath.2013.02.019
|
|
|
[22]
|
Zacharski, L.R. (2010) Hemochromatosis, Iron Toxicity, and Disease. Journal of Internal Medicine, 268, 246-248.
http://dx.doi.org/10.1111/j.1365-2796.2010.02233.x
|
|
|
[23]
|
Raman, S.V., Winner 3rd, M.W., Tran, T., Velayutham, M., Simonetti, O.P., et al. (2008) In Vivo Atherosclerotic Plaque Characterization Using Magnetic Susceptibility Distinguishes Symptom-Producing Plaques. JACC: Cardiovascular Imaging, 1, 49-57.
http://dx.doi.org/10.1016/j.jcmg.2007.09.002
|
|
|
[24]
|
Valenti, L., Dongiovanni, P., Motta, B.M., Swinkels, D.W., Bonara, P., et al. (2011) Serum Hepcidin and Macrophage Iron Correlate with MCP-1 Release and Vascular Damage in Patients with Metabolic Syndrome Alterations. Arteriosclerosis, Thrombosis, and Vascular Biology, 31, 683-690.
http://dx.doi.org/10.1161/ATVBAHA.110.214858
|
|
|
[25]
|
Zidek, W., Tenschert, W., Karoff, C. and Vetter, H. (1985) Tratment of Resistant Hypertension by Phlebotomy. Klinische Wochenschrift, 63, 762-764.
http://dx.doi.org/10.1007/BF01733828
|
|
|
[26]
|
Barenbrock, M., Spieker, C., Rahn, K.H. and Zidek, W. (1993) Therapeutic Efficiency of Phlebotomy in Posttransplant Hypertension Associated with Erythrocytosis. Clinical Nephrology, 40, 241-243.
|
|
|
[27]
|
Ducluzeau, P.H., Fletcher, L.M., Vidal, H., Laville, M. and Tavaré, J.M. (2002) Molecular Mechanisms of Insulin-Stimulated Glucose Uptake in Adipocytes. Diabetes & Metabolism, 28, 85-92.
|
|
|
[28]
|
Ware, W.R. (2013) Iron and Diabetes. Integrative Healthcare Practitioners, 76-81.
|
|
|
[29]
|
Ahmed, U., Latham, P.S. and Oates, P.S. (2012) Interactions between Hepatic Iron and Lipid Metabolism with Possible Relevance to Steatohepatitis. World Journal of Gastroenterology, 18, 4651-4658.
http://dx.doi.org/10.3748/wjg.v18.i34.4651
|
|
|
[30]
|
Fleming, D.J., Tucker, K.L., Jacques, P.F., Dallal, G.E., Wilson, P.W. and Wood, R.J. (2002) Dietary Factors Associated with the Risk of High Iron Stores in the Elderly Framingham Heart Study Cohort. The American Journal of Clinical Nutrition, 76, 1375-1384.
|
|
|
[31]
|
Jehn, M., Clark, J.M. and Guallar, E. (2004) Serum Ferritin and Risk of the Metabolic Syndrome in U.S. Adults. Diabetes Care, 27, 2422-2428.
http://dx.doi.org/10.2337/diacare.27.10.2422
|
|
|
[32]
|
Equitani, F., Fernández-Real, J.M., Menichella, G., Koch, M., Calvani, M., et al. (2008) Bloodletting Ameliorates Insulin Sensitivity and Secretion in Parallel to Reducing Liver Iron in Carriers of HFE Gene Mutations. Diabetes Care, 31, 3-8.
http://dx.doi.org/10.2337/dc07-0939
|
|
|
[33]
|
Lamas, G.A., Goertz, C., Boineau, R., Mark, D.B., Rozema, T., et al. (2013) Effect of Disodium EDTA Chelation Regimen on Cardiovascular Events in Patients with Previous Myocardial Infarction: The TACT Randomized Trial. JAMA, 309, 1241-1250.
http://dx.doi.org/10.1001/jama.2013.2107
|
|
|
[34]
|
Boussageon, R., Supper, I., Bejan-Angoulvant, T., Kellou, N., Cucherat, M., Boissel, J.-P., et al. (2012) Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials. PLoS Medicine, 9, e1001204.
http://dx.doi.org/10.1371/journal.pmed.1001204
|
|
|
[35]
|
Turnbull, F. and Zoungas, S. (2012) Intensive Glucose-Lowering Therapy in People with Type 2 Diabetes, What Do We Learn from a New Meta-Analysis of Randomized Controlled Trials? Evidence-Based Medicine, 17, 98-99.
http://dx.doi.org/10.1136/ebmed-2011-100230
|
|
|
[36]
|
Manco, M. and Fernández-Real, J.M. (2012) Back to Past Leeches: Repeated Phlebotomies and Cardiovascular Risk. BMC Medicine, 10, 53.
http://dx.doi.org/10.1186/1741-7015-10-53
|
|